Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Discover 3 Next-Generation Defence
Stocks Potential 33x Opportunity

*1 out of these 3 stocks have already run up. Act fast or you might completely miss out on this big opportunity.




**Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
**By submitting your email address, you also sign up for Profit Hunter, a Free-for-life newsletter from Equitymaster,
which offers the most profitable investing ideas in India.


AD

NOVATEOR RESEARCH LABORATORIES Share Price   (NOVA)



Here is the latest stock price and chart of NOVATEOR RESEARCH LABORATORIES. For more details, see the NOVATEOR RESEARCH LABORATORIES company fact sheet and quarterly results. Since such stocks interest you, here's a proven approach to making penny stock investments.

REFRESH
Live BSE Quotes Mar 23, 2023 (Close)
Price (Rs)18.50 Open (Rs) 18.50 High (Rs) 18.50 Low (Rs) 18.50
% Change7.25 Volume 6,000 Value (Rs) 111,000 52-Week H/L 26.20 / 8.10
Live NSE Quotes
Not listed
Change
Valuation
EPS (Rs)* - P/E Ratio (x) - Market Cap (Rs m) 89.43 P/BV (x) 1.20 Dividend Yield (%) 0.00
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
  
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

As of September 2022, company promoters held 60.87% stake in , with no shares having been pledged. To know more, check out the latest shareholding pattern of .



FAQs on NOVATEOR RESEARCH LABORATORIES

What is the NOVATEOR RESEARCH LABORATORIES share price today?

The last traded price of NOVATEOR RESEARCH LABORATORIES was Rs 18.5 on the BSE, up 7.3% over the previous close.

What is the market cap of NOVATEOR RESEARCH LABORATORIES?

The current market capitalisation of NOVATEOR RESEARCH LABORATORIES stands at Rs 89 m.


Today's Market

Sensex Today Ends Marginally Higher | Pharma Stocks Rally | Reliance & Grasim Top Gainers Sensex Today Ends Marginally Higher | Pharma Stocks Rally | Reliance & Grasim Top Gainers(Closing)

After opening the day on a positive note, Indian share markets pared some gains in late deals to end marginally higher.

ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.